Tag Archives: MSD

AstraZeneca: Exciting ROpel Phase III trial results demonstrate the potential for Lynparza with abiraterone to become a new 1st-line option for patients with metastatic castration-resistant prostate cancer

Posted on 24, September 2021 by

(PRESS RELEASE) CAMBRIDGE, 24-Sep-2021 — /EuropaWire/ — AstraZeneca (LSE/STO/Nasdaq: AZN), a British–Swedish multinational pharmaceutical and biopharmaceutical company, has announced positive high-level results from the PROpel Phase III trial showed AstraZeneca and MSD’s Lynparza (olaparib) in combination with abiraterone demonstrated a … Read the full press release →

Posted in Healthcare, News, Pharma & Biotech, Science, Technology, United Kingdom

Tagged , , , , , , , , , , , , , , , , , , , ,

Sanofi Pasteur and MSD to separately pursue their own vaccine strategies in Europe

Posted on 3, January 2017 by

PARIS, 03-Jan-2017 — /EuropaWire/ — Sanofi and its vaccines global business unit Sanofi Pasteur confirmed today the end of their vaccine joint-venture with MSD (known as Merck & Co. Inc., in the United States and Canada), Sanofi Pasteur MSD (SPMSD). … Read the full press release →

Posted in Business, France, Healthcare, Pharma & Biotech

Tagged , , , ,

Maris Interiors LLP completes office design & relocation project for MSD in London

Posted on 7, April 2015 by

LONDON, 7-4-2015 — /EuropaWire/ — Maris Interiors LLP has completed an office design & relocation project for MSD in London. This project is at the new office space at 2 Pancras Square in London. Merck, Sharp & Dohme appointed Maris … Read the full press release →

Posted in Business, Healthcare, Management, Real Estate, United Kingdom

Tagged , , , , ,